<DOC>
	<DOC>NCT01367626</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Letrozole Tablet under fed conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Letrozole</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to letrozole or any comparable or similar product.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>